These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8086333)

  • 1. Management of arrhythmias in hypertrophic cardiomyopathy.
    Stewart JT; McKenna WJ
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):95-9. PubMed ID: 8086333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmia and prognosis in hypertrophic cardiomyopathy.
    McKenna WJ
    Eur Heart J; 1983 Nov; 4 Suppl F():225-34. PubMed ID: 6686539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A primer on arrhythmias in patients with hypertrophic cardiomyopathy.
    Bockstall KE; Link MS
    Curr Cardiol Rep; 2012 Oct; 14(5):552-62. PubMed ID: 22825919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy.
    Weidemann F; Maier SK; Störk S; Brunner T; Liu D; Hu K; Seydelmann N; Schneider A; Becher J; Canan-Kühl S; Blaschke D; Bijnens B; Ertl G; Wanner C; Nordbeck P
    Am J Cardiol; 2016 Jul; 118(2):264-74. PubMed ID: 27265676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmia and hypertrophic cardiomyopathy.
    Shakespeare CF; Keeling PJ; Slade AK; McKenna WJ
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():31-6. PubMed ID: 1307192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy.
    McKenna WJ; Franklin RC; Nihoyannopoulos P; Robinson KC; Deanfield JE
    J Am Coll Cardiol; 1988 Jan; 11(1):147-53. PubMed ID: 3335690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification for arrhythmic events in patients with nonischemic dilated cardiomyopathy and nonsustained ventricular tachycardia: role of programmed ventricular stimulation and the signal-averaged electrocardiogram.
    Turitto G; Ahuja RK; Caref EB; el-Sherif N
    J Am Coll Cardiol; 1994 Nov; 24(6):1523-8. PubMed ID: 7930285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmias in hypertrophic cardiomyopathy.
    Kuck KH
    Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 2):2706-13. PubMed ID: 9358518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy].
    Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
    Pol Merkur Lekarski; 2017 Feb; 42(248):65-70. PubMed ID: 28258679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.
    Neri R; Mestroni L; Salvi A; Pandullo C; Camerini F
    Am Heart J; 1987 Mar; 113(3):707-15. PubMed ID: 3825860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arrhythmias of primary hypertrophic cardiomyopathy].
    Babuty D; Fauchier L; Nguyen D; Giraudeau C; Marie O; Fauchier JP; Cosnay P
    Arch Mal Coeur Vaiss; 2003 Dec; 96 Spec No 7():7-15. PubMed ID: 15272516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
    McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF
    Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ambulatory ECG in cardiomyopathies].
    Mestroni L; Miani D; Neri R; Di Lenarda A; Camerini F
    G Ital Cardiol; 1987 Dec; 17(12):1139-44. PubMed ID: 3503812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy: the importance of arrhythmic events in patients at risk for sudden cardiac death.
    Medeiros Pde T; Martinelli Filho M; Arteaga E; Costa R; Siqueira S; Mady C; Piegas LS; Ramires JA
    Arq Bras Cardiol; 2006 Nov; 87(5):649-57. PubMed ID: 17221043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic aspects of the etiology of arrhythmia].
    Thierfelder L
    Z Kardiol; 2000; 89 Suppl 3():1-5. PubMed ID: 10810779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.